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ABSTRACT
Talin binds to β-integrin tails to activate integrins, regulating cell
migration, invasion and metastasis. There are two talin genes, TLN1
and TLN2, encoding talin1 and talin2, respectively. Talin1 regulates
focal adhesion dynamics, cell migration and invasion, whereas the
biological function of talin2 is not clear and, indeed, talin2 has been
presumed to function redundantly with talin1. Here, we show that
talin2 has a much stronger binding to β-integrin tails than talin1.
Replacement of talin2 Ser339 with Cys significantly decreased its
binding to β1-integrin tails to a level comparable to that of talin1.
Talin2 localizes at invadopodia and is indispensable for the
generation of traction force and invadopodium-mediated matrix
degradation. Ablation of talin2 suppressed traction force generation
and invadopodia formation, which were restored by re-expressing
talin2 but not talin1. Furthermore, re-expression of wild-type talin2
(but not talin2S339C) in talin2-depleted cells rescued development of
traction force and invadopodia. These results suggest that a strong
interaction of talin2 with integrins is required to generate traction,
which in turn drives invadopodium-mediated matrix degradation,
which is key to cancer cell invasion.
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INTRODUCTION
Talin activates integrin and plays a pivotal role in cell migration,
invasion and cancer metastasis (Desiniotis and Kyprianou, 2011;
Huang et al., 2009; Jin et al., 2015; Tadokoro et al., 2003). Talin
contains an N-terminal globular head domain and a C-terminal rod
domain (Goult et al., 2013; Nuckolls et al., 1990). The talin head
domain contains a FERM domain and is responsible for the binding
of talin to β-integrin tails (Calderwood et al., 1999). The rod domain
has several vinculin-binding sites and two actin-binding sites
(Atherton et al., 2015; Gingras et al., 2005; Hemmings et al., 1996).
The binding of talin to β-integrin tails is essential for integrin
activation (Calderwood et al., 1999; Tadokoro et al., 2003), which
in turn regulates focal adhesion dynamics and invadopodium
formation (Bate et al., 2012; Beaty et al., 2014; Franco et al., 2004;
Nayal et al., 2004) – key steps in cell migration and invasion (Beaty
and Condeelis, 2014; Saykali and El-Sibai, 2014;Webb et al., 2002;
Wehrle-Haller, 2012). Talin also mediates calpain-induced focal
adhesion disassembly (Bate et al., 2012; Franco et al., 2004). Talin1
phosphorylation by Cdk5 regulates focal adhesion dynamics,
integrin activation, cell migration, invasion and metastasis
(Huang et al., 2009; Jin et al., 2015). Talin interacts with
phosphatidylinositol phosphate kinase γ, which produces
phosphatidylinositol 4,5-bisphosphate (PIP2) to regulate focal
adhesion dynamics, cell migration and invasion (Chen et al.,
2015; Di Paolo et al., 2002; Li et al., 2013; Ling et al., 2002; Wu
et al., 2011). It recruits the moesin–NHE1 complex to modulate pH
at invadopodia, consequently governing invadopodium stability and
matrix degradation (Beaty et al., 2014). It is also required for the
initial generation of mechanical force (Giannone et al., 2003; Zhang
et al., 2008).
There are two talin genes, TLN1 and TLN2, encoding talin1 and
talin2, respectively. Talin1 has been well studied, whereas the
biological function of talin2 is less clear. It has been shown that
talin2 regulates focal adhesion assembly and focal adhesion kinase
(FAK) signaling in the absence of talin1 (Zhang et al., 2008). Talin2
is usually localized at large focal adhesions and fibrillar adhesions,
whereas talin1 is usually found at smaller focal adhesions in the
peripheral region (Praekelt et al., 2012; Senetar et al., 2007).
Trastuzumab, an antibody therapeutic targeting HER2 for the
treatment of cancer, inhibits cell migration and invasion by
downregulating talin2 (Le et al., 2012). Nevertheless, it has been
reported that depletion of talin2 does not influence β1-integrin
activation (Jin et al., 2015). Thus, it had been presumed that talin2
functions redundantly with talin1.
In the present study, we demonstrate that talin2 functions
distinctly from talin1 as a regulator of cell invasion. We show that
talin2 has a stronger interaction with β-integrin tails than talin1, and
that it colocalizes with invadopodia, regulates the generation of
traction force and invadopodium-mediated matrix degradation.
Furthermore, the strong interaction of talin2 with β-integrin tails is
essential for the development of strong traction and invadopodia, as
replacement of Ser339 with Cys in the talin2 head domain
compromises binding to β-integrin tails, and inhibits traction force
and invadopodium-mediated matrix degradation. Recently, a
disease-causing missense variant, S339L, of the TLN2 gene has
been identified as the cause of fifth finger camptodactyly, a digit
deformity in humans (Deng et al., 2016), which occurred in the
presence of talin1, further highlighting distinct roles of talin1 and
talin2 in development. This also demonstrates the physiological
relevance of residue S339 in talin2 function and the requirement
for strong talin2–integrin linkage in normal development. Thus,
interaction of talin2 with integrins is required for the generation ofReceived 12 January 2016; Accepted 18 August 2016
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traction force, which in turn drives invadopodium-mediated matrix
degradation, and ultimately, cancer cell invasion.
RESULTS
Talin2 binds to β-integrin tails more strongly than talin1
To learn whether talin1 and talin2 have any difference in binding to
β-integrin tails, CHO-K1 cells were transfected with EGFP–talin-
head constructs – EGFP–talin11–433, EGFP–talin11–446 or EGFP–
talin21–449 – and binding to integrin tails was determined by
GST–β-integrin-tail pulldown assays, using GST as a control. The
interaction of talin21–449 with the tail of β1A-integrin (an isoform
encoded by ITGB1) was more efficient than that of either talin11–433
or talin11–446 (Fig. 1A). Similar results were observed with the
binding of the tails of the β3A-integrin and β1D-integrin (isoforms
encoded by ITGB3 and ITGB1, respectively) (Fig. S1A). Deletion
of the C-terminus of the FERM domain enhanced the binding of
talin21–449 to β1A-integrin tails (Fig. 1B) but reduced the binding of
talin11–446 (Fig. 1C). The difference between talin1 and talin2 in
integrin binding was not caused by other associated proteins in the
cell lysates, because purified His-tagged talin21–449 binding to β1A-
integrin tail was also stronger than that of purified talin11–443 and
talin11–446 (Fig. 1D). Thus, the talin2 head domain (TH2) has a
much higher affinity than the talin1 head domain (TH1) for
β-integrin tails.
Talin1 residueC336and talin2 residueS339contribute to the
isoform-specific affinity differences
To identify why talin2 binding to integrins is stronger than talin1,
we aligned the sequences of talin1 and talin2 around the integrin-
binding site in the F3 FERM subdomain. There are several residues
that are different between the integrin-binding sequences of talin1
and talin2 (Fig. 1E). Replacement of Cys336 of talin1 with Ser
enhanced the binding of talin1 to the β1A-integrin tail to an extent
comparable to that of talin2 (Fig. 1F), whereas replacement of
Ser339 on talin2 with Cys substantially attenuated its binding
(Fig. 1G). Replacement of Cys336 on talin1 with other residues
dramatically changed its binding to the β1A-integrin tail (Fig. S1B),
whereas mutation at several other mismatching residues had no
effect on the ability of talin1 to bind to integrin tails (data not
shown). The recent finding that mutation of Ser339 to Leu in talin2
has a disease-causing phenotype in humans, giving rise to the
pathology fifth finger camptodactyly, highlights the physiological
importance of this residue. Indeed, a S339L mutant has a similar
effect to that of S339C on integrin binding (Fig. 1H). Similar
results were observed in pulldown assays using purified His-tagged
Tln11–446, Tln21–449 and mutants (Fig. 1I). These data indicate
that Ser339 plays an important role in the high integrin-binding
ability of talin2.
Talin2 is essential for the assembly of large, stable focal
adhesions and generation of traction force
To ascertain whether talin2 is different from talin1 in regulating
focal adhesions, we used CRISPR–Cas9 to knockout talin1 or talin2
from U2OS cells. Ablation of talin isoforms was achieved by
infecting the cells with lentiviruses that express Cas9 and talin1 or
talin2 guide (g)RNAs (Fig. 2A). The talin1- or talin2-null
(knockout) cells were plated on fibronectin and stained for zyxin
and either talin1 or talin2, using cells expressing empty
LentiCRISPR v2 vector as a control. Ablation of either talin1 or
talin2 inhibited the assembly of small focal adhesions (<7 µm2), as
determined with staining of zyxin staining (Fig. 2B and C).
However, ablation of talin1 did not influence large focal adhesions
(>10 µm2), whereas knockout of talin2 significantly diminished the
formation of large focal adhesions (Fig. 2C, bottom panel). Similar
results were observed in cells where talin1 or talin2 were depleted
using small hairpin (sh)RNAs (Fig. S2A–C). In the central regions
(>5 µm from edges) of U2OS cells, a higher number of large spots
of talin2 were visible than those of talin1 (Fig. 2D). Likewise, in
MDA-MB-231 and MDA-MB-435S cancer cells, talin1 was
usually found in smaller focal adhesions, whereas talin2 formed
larger focal adhesions (Fig. S2D and E). However, although
ablation of talin1 also confined the assembly of FAK to small focal
adhesions (<7 µm2), ablation of talin2 had little effect on FAK
localization (Fig. 2E and F). These results suggest that talin2 is
mainly responsible for large, stable focal adhesion assembly,
whereas talin1 mediates smaller focal adhesion formation.
To compare the roles of talin1 and talin2 in the generation of
traction force, talin1- or talin2-ablated U2OS cells were plated onto
fibronectin-conjugated polyacrylamide gels containing Red
FluoSpheres, using cells carrying empty CRISPR vector as a
control. Traction force was measured using a Nikon A1 confocal
microscope equipped with a CO2 incubator system and analyzed
using the method of Butler et al. (2002). Knockout of talin1 or talin2
significantly inhibited the traction force generated (Fig. 3A and C).
Talin1 knockout also significantly depressed the cell spreading on
the polyacrylamide gel, whereas talin2 knockout had only marginal
effects (Fig. 3B), suggesting that the effect of talin1 knockout on
traction force might be caused by suppression of cell spreading.
Because the TH1 has been reported to mediate cell spreading in
talin1-knockout cells (Zhang et al., 2008), we examined whether
transfection of TH1 could rescue the traction force production in
talin1-null cells. Talin1-null U2OS cells were transfected with
EGFP–talin11–446 (constituting TH1) or EGFP–talin21–449
(constituting TH2) (Fig. 4A). The cells were plated on
polyacrylamide gels containing Red FluoSpheres for analysis in
cell spreading and traction force assays, using talin1-knockout cells
as a control. Transfection of talin1-knockout cells with TH1
significantly rescued the cell-spreading defect, whereas transfection
with TH2 had no effect (Fig. 4B and C). TH1-mediated cell
spreading was accompanied by an increase in traction force, whereas
TH2was unable to rescue the cell-spreading and traction-force defect
caused by the ablation of talin1 (Fig. 4B and D). Because the talin
head domain lacks the predominant actin-binding site (Atherton
et al., 2015), it is deficient in mediating traction force production.
These results suggest that the apparent role of talin1 in the generation
of traction force is partially caused by its effect on cell spreading.
To explore whether talin2 is dispensable for traction force
generation, talin2-knockout U2OS cells were transfected with full-
length EGFP–talin1 or EGFP–talin2 (Fig. 4E), and the traction force
in these cells was determined, using talin2-knockout cells and
CRISPR vector cells as controls. Transfection with talin1 caused
only a slight increase in traction force, whereas transfection with
talin2 almost restored the traction force to the levels of CRISPR
control cells (Fig. 4F). The role of talin2 in traction force production
is further supported by shRNA knockdown experiments, where
depletion of talin2 caused a significant reduction in traction force
production in U2OS cells and MDA-MB-231 cells (Fig. S3). These
results indicate that talin2 is indispensable for cellular traction force
generation.
Strong binding of talin2 to integrins is essential for the
development of traction force
To stably express full-length talin2 and talin2S339C in talin2-null
U2OS cells, pAAVS1-EGFP-talin2WT or pAAVS1-EGFP–
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talin2S339C were co-transfected with AAVS1 gRNA into
talin2-null U2OS cells. The cells were selected with neomycin
and sorted for EGFP-positive cells. The expression of EGFP–
talin2 and EGFP–talin2S339C was examined by western blotting
(Fig. 5A). To examine whether the strong binding of talin2 to
β-integrins is essential for traction force generation, talin2-
null cells that expressed EGFP–talin2 or EGFP–talin2S339C
were plated onto the gelatin-conjugated polyacrylamide gels
Fig. 1. Talin2 has a much higher affinity than talin1 for β-integrin tails. (A–C) Binding of talin-truncated mutants to β1A-integrin tails, measured by using GST
pulldown assays. The EGFP fusion proteins of talin mutants were transiently expressed in CHO-K1 cells. (A) Binding of EGFP–talin11–433 (Tln11–433),
EGFP–talin11–446 (Tln11–446) and EGFP–talin21–449 (Tln21–449). (B) Binding of EGFP–talin11–446, EGFP–talin21–449, EGFP–talin21–403 (Tln21–403) and
EGFP–talin2389-449 (Tln2389–449). (C) Binding of EGFP–talin11–446, EGFP–talin11–401 (Tln11–401), EGFP–talin1395-446 (Tln1395–446) and EGFP–talin21–449.
(D) Interaction of purified His-tagged talin11–446 and talin21–449 to immobilized GST and GST–β1A-integrin-tails. The binding was detected by Coomassie
staining. (E) Sequence alignment of the integrin-binding region of the F3 FERM domains of talin1 and talin2. Residues C336 in talin1 and S339 in talin2 are shown
in red. Yellow and red lines indicate unmatched residues with similar and different chemical properties, respectively. (F–H) The EGFP fusion proteins of talin
mutants were transiently expressed in CHO-K1 cells. The binding of talin mutants to β1A-integrin tails was determined byGST pulldown assays. (F) Substitution of
talin1 residue C336 with Ser promoted its binding to β1A-integrin tails. (G) Replacement of talin2 S339 with Cys reduced its binding to β1A-integrin tails.
(H) Replacement of talin2 S339 with Leu diminished its binding to β1A-integrin tails. (I) Binding of purified His-tagged talin11–446, talin11–446
C336S, talin21–449 and
talin21–449
S339C to immobilized GST and GST–β1A-integrin-tails. Binding was detected by Coomassie staining.
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containing Red FluoSpheres, and traction force was measured
using talin2-null cells and CRISPR vector cells as controls.
Expression of EGFP–talin2 in talin2-null cells restored
more than 70% of the traction force as compared to that of
CRISPR vector cells, whereas that of EGFP–talin2S339C, which
has reduced affinity to β-integrins, had little effect (Fig. 5B and C).
This result suggests that a strong binding of talin2 to β-integrins is
required for traction force generation.
Fig. 2. Talin1 is required for small focal adhesion formation, whereas talin2 is responsible for large, stable focal adhesion assembly. (A) Endogenous
talin1 and talin2 in CRISPR-vector-transfected (CRISPR Ctrl) U2OS cells and talin1- or talin2-null (Tln1 KO and Tln2 KO, respectively) U2OS cells. Numbers
represent different clones. (B) The distribution of zyxin and talin1 (top) or talin2 (bottom) in talin1- and talin2-null cells. Talin1- or talin2-null U2OS cells were plated
onto fibronectin- (5 μg/ml) coated glass-bottomed dishes for 4 h, fixed and co-stained for talin1 (or talin2) and zyxin. Images were acquired by using TIRF
microscopy. Scale bar: 20 μm. (C) Area distribution of zyxin staining in talin1- (top) and talin2- (middle) null U2OS cells. The small graph at the bottom highlights
the different effects of talin1 and talin2 knockout on large (>10 µm2) focal adhesions. Data are mean±s.e.m. of three experiments. In each experiment, focal
adhesions of 20 cells from each group were analyzed and plotted. 10-INF represents FAs larger than 10 µm2. Tln1-62, Tln1-123, Tln2-4 and Tln2-22
represent different clones of talin1 or talin2 KO cells. t-test, *P<0.05, **P<0.01, ***P<0.001 against CRISPRcontrol cells, unless specified otherwise in the figures.
(D) Area distribution of talin1 and talin2 staining in central parts (5 µm from edges) of cells. Data are mean±s.e.m. of three experiments. t-test, *P<0.05. (E) The
distribution of phosphorylated FAK at Y397 (pY397-FAK) in talin1- or talin2-null cells. Talin1- or talin2-null U2OS cells were cultured on fibronectin, fixed and
stained for pY397-FAK. Scale bar: 20 μm. (F) Area distribution of pY397-FAK staining in talin1- (left) and talin2- (right) null U2OS cells. Data are means of two
experiments. In each experiment, focal adhesions of 20 cells from each group were analyzed and plotted.
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Strong binding of talin2 to integrins is required for cell
invasion
To examine the role of talin1 and talin2 in cell invasion, talin1- or
talin2-ablated U2OS cells were examined for their capacity to
penetrate through Transwell filters coated with Matrigel. As shown
in Fig. 6A and B, ablation of either talin1 or talin2 inhibited
the invasion of U2OS cells. Knockout of talin1 or talin2 caused
∼77–91% inhibition of U2OS cell invasion, as compared to that of
CRISPR vector cells. This crucial role of talin1 and talin2 in cell
invasion was also observed in MDA-MB-231 cells (Fig. 6C). These
results indicate that both talin1 and talin2 play crucial roles in
cell invasion.
To determine the essential role of the talin2–β-integrin interaction
in cell invasion, talin2-nullU2OScells that expressedEGFP–talin2 or
EGFP–talin2S339C were tested for their invasive capacities toward
Matrigel, using talin2-null cells and CRISPR vector cells as controls.
Expression of EGFP–talin2 in talin2-null cells significantly rescued
the capacity of the cells to invade, whereas expression of EGFP–
talin2S339C had only a small effect (Fig. 6D and E), suggesting that
strong binding of talin2 to integrins is required for cell invasion.
Talin2 colocalizes with invadopodia and regulates matrix
degradation
To examine the colocalization of talin2 with invadopodia, U2OS cells
were plated on Cy3-labeled gelatin that was immobilized on glass-
bottomed dishes, and cells were co-stained for talin2 and the
invadopodium markers cortactin or Tks5. Talin2 significantly
colocalized with cortactin and Tks5 at either large or small
degradation holes (Fig. 7A and B). Only about 80% of invadopodia
contained both cortactin and talin2, suggesting that talin2 and cortactin
contribute to different stages of invadopodia. MDA-MB-231 cells had
more invadopodia, in which talin2 colocalized with cortactin,
as compared to that observed in U2OS cells (Fig. 7C). Talin1
also colocalized with cortactin at invadopodia in MDA-MB-231 cells
(Fig. S4A). We then examined the colocalization of talin2 with two
other invadopodium markers – β1-integrin and N-WASP. β1-integrin
and talin2 colocalized with gelatin degradation holes, whereas
β1-integrin at focal adhesions did not (Fig. S4B). Talin2 also
colocalized with N-WASP at invadopodia-like structures (Fig. S4C).
These results suggest that talin2 is a marker for invadopodia.
To determine the roles of talin1 and talin2 in invadopodia, talin1-
or talin2-ablated U2OS cells were plated on Alexa-Fluor-488-
labeled gelatin and stained for filamentous actin. Although ablation
of either talin1 or talin2 dramatically inhibited invadopodium-
mediated matrix degradation, knockout of talin2 had a slightly more
severe effect on invadopodia formation than did talin1 knockout
(Fig. 7D and E), suggesting a key role of talin2 in invadopodium
regulation.
To examine whether talin2 is indispensable for invadopodium-
mediated matrix degradation, talin2-knockout U2OS cells were
Fig. 3. The roles of talin1 and talin2 in cell spreading and traction force production. (A) Effects of talin1 and talin2 knockout (Tln1 KO 62 and Tln2 KO 22,
respectively) on cell spreading and traction force generation in U2OS cells. Axis labels are pixel numbers. Scale bar: 30 μm. (B) Quantitative cell spreading
area in talin1- or talin2-ablated U2OS cells, using cells carrying CRISPR vector (CRISPR Ctrl) as a control. Data are presented as mean±s.e.m. of three
experiments. In each experiment, 30 cells from each group were analyzed. t-test, *P<0.05, ***P<0.001 compared to control. (C) Quantitative constrained traction
force in talin1- or talin2-ablated U2OS cells, using cells carrying CRISPR vector as a control. Data are presented as mean±s.e.m. of three independent
experiments. t-test, ***P<0.001.
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transfected with full-length EGFP–talin1 or EGFP–talin2, and the
matrix degradation capabilities of these cells were determined,
using talin2-knockout and CRISPR vector cells as controls.
Transfection with talin1 did not significantly improve
invadopodia-mediated matrix degradation, whereas transfection
with talin2 rescued the invadopodia activity in talin2-knockout cells
Fig. 4. Talin2 is indispensable for traction force generation. (A) Expression of EGFP–talin1 head domain (TH1) and –talin2 head domain (TH2) in talin1-
knockout (KO) U2OS cells. (B–D) Expression of TH1 but not TH2 partially rescued the cell-spreading and traction force defect caused by talin1 knockout.
(B) Talin1-knockout U2OS cells were transiently transfected with EGFP–TH1 or EGFP–TH2, and cultured on polyacrylamide gel containing Red FluoSpheres in
order to determine the cell spreading and traction force, using CRISPR-vector-infected cells and talin1-knockout cells as controls. Axis labels are pixel numbers.
Scale bar: 30 µm. (C) Cell spreading areas on polyacrylamide gel. Data are presented as mean±s.e.m. of three experiments. In each experiment, 30 cells from
each group were analyzed. t-test, **P<0.01. (D) Quantification of constrained traction force. Data are presented as mean±s.e.m. of three independent
experiments. In each experiment, more than 30 cells from each group were analyzed. t-test, **P<0.01. (E) Transient expression of full-length EGFP–talin1 and
EGFP–talin2 in talin2-knockout U2OS cells. (F) Re-expression of full-length EGFP–talin2 rescues the traction force defect caused by talin2 knockout, whereas re-
expression of talin1 only induced a slight increase in traction force. Data are presented as mean±s.e.m. of four experiments. In each experiment, more than 40
cells from each group were analyzed. t-test, *P<0.05, ***P<0.001.
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(Fig. 7F and G). Using shRNA to deplete talin2 also caused a
significant reduction in invadopodium formation in U2OS cells
(Fig. S4E). However, talin2-knockout did not affect the
invadopodium-like pattern of cortactin staining (Fig. S4D). These
results suggest that talin2 is indispensable for invadopodium-
mediated matrix degradation.
Talin2-mediated traction force drives invadopodium-
mediated matrix degradation
To learn whether the traction force distribution is associated with
invadopodia, U2OS cells were plated on Alexa-Fluor-488-gelatin-
conjugated polyacrylamide gels containing Red FluoSpheres.
Invadopodia and traction force were measured simultaneously
using a Nikon A1 confocal microscope. As shown in Fig. 8A and B,
areas of bead displacement (indicating generation of traction force)
were colocalized with ∼65% invadopodia-generated degradation
holes, suggesting that traction force regulates invadopodium-
mediated matrix degradation.
To examine whether talin2-mediated traction force regulates
invadopodium-mediated matrix degradation, talin2-null U2OS cells
that stably expressed EGFP–talin2 or EGFP–talin2S339C were plated
onto glass-bottomed dishes coated with Cy3-gelatin, and talin2-
knockout and CRISPR vector cells were used as controls. Talin2-
expressing cells formed invadopodium-like structures, whereas
talin2S339C-expressing cells did not (Fig. 8C and D). Expression of
talin2 in talin2-null cells completely restored invadopodium-
mediated matrix degradation, whereas expression of talin2S339C,
which cannot restore the ability of cells to generate traction force,
did not (Fig. 8E).
To test the role of talin2-mediated traction force in invadopodia
in another cell line, talin2 expression in MDA-MB-231 cells
was ablated by infecting the cells with lentiviruses that encoded
Cas9 and talin2 gRNAs. AAVS1 gRNA was co-transfected
with pAAVS1-EGFP-talin2WT or pAAVS1-EGFP-talin2S339C into
talin2-null cells. The expression of EGFP–talin2 and EGFP–
talin2S339C in talin2-null MDA-MB-231 cells was detected using an
Fig. 5. Strong binding of talin2 to β-integrin tails is required for traction force generation. (A) Stable expression of EGFP–talin2 and talin2S339C in talin2-null
(Talin2 KO) U2OS cells by using CRISPR. (B,C) Re-expression of wild-type talin2 (Talin2WT) in talin2-null cells restored their ability to generate traction force, but
that of talin2S339C did not. (B) Talin2-null U2OS cells that expressed EGFP–talin2 (Tln2WT) or EGFP–talin2S339C (Tln2S339C) were cultured on polyacrylamide
gel containing Red FluoSpheres in order to determine traction force, using CRISPR-vector-infected cells and talin2-null cells as controls. Axis labels are
pixel numbers. Scale bar: 30 μm. (C) Quantification of constrained traction force. Data are presented as mean±s.e.m. of three experiments. In each experiment,
more than 30 cells from each group were analyzed. t-test, *P<0.05, **P<0.01.
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antibody against talin2 (Fig. 8F). Similar to the results observed in
U2OS cells, talin2 markedly restored invadopodia formation in
talin2-null MDA-MB231 cells, whereas talin2S339C had little effect
(Fig. 8G and H). Thus, talin2-mediated traction force might regulate
invadopodium-mediated matrix degradation.
DISCUSSION
In invasive cells, talin2 generates strong traction forces through its
high affinity for β-integrins, driving invadopodium-mediated matrix
degradation and ultimately, cell invasion (Fig. 8I). Thus, talin2
binding to β-integrin tails is indispensable for cancer cell invasion.
We found that talin2 binds to integrin tails stronger than talin1
does and that the talin2 residue S339 contributes to its strong
interaction with β-integrins. Substitution of S339 with Cys caused a
reduction in its binding to integrins, whereas the reciprocal mutation
of talin1 C336 to Ser enhanced talin1 binding (Fig. 1). Our data are
different from the results of a previous report (Anthis et al., 2009), in
which the F3 FERMdomains of talin1 and talin2 were found to bind
to β1A-integrin tails with a Kd of 491 and 652 μM, respectively, as
measured by using nuclear magnetic resonance NMR. In our study,
we found that talin2 had a stronger interaction with β-integrin tails
than talin1; this discrepancy is probably because we used the full-
length talin2 head domain, whereas the F3 domain alone was used
by Anthis et al. (2009). Indeed, the talin2 head domain bound to
β1A-integrin tails much more efficiently than the F2–F3 FERM
domain (Fig. S1C). This is consistent with a previous report
(Calderwood et al., 1999). The discrepancy could be also caused by
the different buffers used in the assays, where we included 3 mg/ml
BSA or 0.5 mg/ml gelatin in our binding buffer to reduce non-
specific binding. Our findings provide a molecular basis to explain
the different roles of talin1 and talin2.
Talin1 and talin2 have distinct roles in regulating focal adhesion
assembly. Based on staining of FAK and zyxin, knockout or
knockdown of talin1 inhibited the formation of small focal
adhesions (<7 μm2), but had no effect on large focal adhesions
(>7 μm2) (Fig. 2; Fig. S2). Knockout or knockdown of talin2 also
suppressed zyxin localization to focal adhesions but did not
influence the recruitment of FAK to focal adhesions. These results
are consistent with previous findings obtained in talin1-knockout
cells (Zhang et al., 2008). Because Zyxin is a marker for focal
adhesion maturation (Zaidel-Bar et al., 2003), these results suggest
that talin1 regulates small focal adhesion assembly, whereas talin2
controls larger, more stable focal adhesion formation. Talin1-
mediated smaller focal adhesions might contribute to focal adhesion
dynamics and cell migration (Huang et al., 2009), whereas the
ability of talin2 to aggregate into large assemblies might stabilize
invadopodia.
We found that talin2 plays an important role in traction force
generation. Knockout or knockdown of talin2 suppressed traction
force generation (Fig. 3; Fig. S3). Moreover, the traction force in
talin2-knockout cells can be rescued by transfecting cells with
talin2, but not with talin1, indicating the indispensable role of talin2
in traction force generation (Fig. 4). Furthermore, talin2-mediated
traction force is dependent on its strong interaction with integrin
tails (Fig. 5). Talin2-mediated traction force generation could be
related to the role of talin2 in large focal adhesion formation,
because focal adhesions regulate traction force generation
(Dumbauld et al., 2013; Hinz and Gabbiani, 2003; Morimatsu
et al., 2015). Ablation of talin1 caused a reduction in traction force,
but this effect can be partially attributed to the role of talin1 in cell
spreading (Figs 3 and 4) because: (1) knockout of talin1 also
inhibited cell spreading (Fig. 3), and (2) expression of the talin1
head domain in talin1-null cells promoted spreading and traction
force generation (Fig. 4). The talin1 head domain retains the
integrin-activating function of talin1, thus promoting cell spreading
(Calderwood et al., 1999; Zhang et al., 2008). However, it lacks the
Fig. 6. Strong binding of talin2 to integrins is required for cell invasion. (A) Representative images showing that the ablation of either talin1 or talin2 (Tln1 KO
and Tln2 KO, respectively) inhibited the invasion of U2OS cells. (B) Quantification of data from the experiment described in A. Data are presented asmean±s.e.m.
from three independent experiments. t-test, *P<0.05, **P<0.01 compared to CRISPR control cells. (C) Depletion of either talin1 or talin2 using shRNAs inhibited
the invasion of MDA-MB-231 cells. Data are presented as mean±s.e.m. from three independent experiments. t-test, **P<0.01, ***P<0.001 compared to shRNA
control cells. (D) Talin2-null U2OS cells that expressed EGFP–talin2 (Tln2WT) or EGFP–talin2S339C (Tln2S339C) were examined for their Matrigel invasive
capacities, using CRISPR-vector-infected cells and talin2-null cells as controls. Representative images are shown. (E) Quantification of data from the experiment
described in D. Data are presented as mean±s.e.m. from three independent experiments. t-test, *P<0.05. w/, with; w/o, without.
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major actin binding site and is deficient in mediating traction force
(Zhang et al., 2008). The distinct roles of talin1 and talin2 in cell
spreading and traction force could be caused by their different
binding affinities toward β-integrins. This assertion is supported
by the deficiency of talin2S339C in mediating traction force (Fig. 5).
It is possible that the different mechanical properties between talin1
and talin2 rod domains could contribute to traction force
generation (Austen et al., 2015). Taken together, it is likely that
Fig. 7. Talin2 is indispensable for invadopodium-mediated matrix degradation. (A,B) Talin2 colocalized with cortactin (A) and Tks5 (B) at invadopodia
in U2OS cells plated on Cy3-labeled gelatin for 16 h. Cells were co-stained with chicken anti-talin2 and rabbit anti-cortactin antibodies (A), or with anti-talin2 and
anti-Tks5 (B) antibodies. Representative TIRF images are shown. Arrowheads point to mature invadopodia in which talin2 colocalized with cortactin (A) or Tks5
(B). Insets showmagnified images of small invadopodia in the box. Scale bars: 20 µm.Graphs show themean number of degradation spots with cortactin (left bar)
and with both cortactin and talin2 (right bar) (A), or with Tks5 (left bar) and with both Tks5 and talin2 (right bar) (B). Data are presented as mean±s.e.m. of 40 cells
from two independent experiments. (C) Talin2 colocalized with cortactin at invadopodia in MDA-MB-231 cells plated on Cy3-labeled gelatin for 10 h. t-test,
***P<0.001. (D) Ablation of either talin1 or talin2 inhibited invadopodium-mediated matrix degradation. Talin1- or talin2-null (Tln1 KO 119 and Tln2 KO 28,
respectively) U2OS cells were cultured on Alexa-Fluor-488-gelatin immobilized on glass-bottomed dishes, fixed and stained with Alexa-Fluor-647–phalloidin.
Scale bar: 20 μm. (E) Quantification of data from the experiment described in D. Data are presented as mean±s.e.m. of three independent experiments. In each
experiment, 20 cells from each group were analyzed. t-test, *P<0.05, **P<0.01, ***P<0.001. (F) Re-expression of full-length EGFP–talin2, but not of EGFP–talin1,
restored invadopodial matrix degradation in talin2-null (Tln2-KO) cells. Talin2-knockout U2OS cells were transiently transfected with full-length EGFP–talin1 or
EGFP–talin2, and cultured on Cy3–gelatin immobilized on glass-bottomed dishes, fixed and stained with Alexa-Fluor-647–phalloidin, using CRISPR-vector-
infected cells and talin2-knockout cells as controls. Scale bar: 20 µm. (G) Quantification of the data from the experiment described in F. Data are presented as
mean±s.e.m. of three independent experiments. t-test, **P<0.01. Representative images are shown.
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Fig. 8. Strongbinding of talin2 to β-integrin tails is indispensable for invadopodium-mediatedmatrix degradation. (A) The distribution of traction forcewas
associated with invadopodia. USOS cells were cultured on Alexa-Fluor-488–gelatin immobilized on acrylamide gel containing Red FluoSpheres. Traction force
and invadopodium formation were determined using an A1 confocal microscope. Scale bar: 30 μm. (B) Quantification of the association of traction force and
invadopodia. The gelatin degradation images were merged with traction force maps, and colocalization was examined manually. Data are presented as mean±
s.e.m. of 24 cells from three independent experiments. (C–E) Stable expression of EGFP–talin2 (Talin2 WT) in talin2-null (Tln2 KO) U2OS cells restored
invadopodial matrix degradation, but that of EGFP–talin2S339C did not. (C) Talin2-null U2OS cells that stably expressed EGFP–talin2 or EGFP–talin2S339C were
cultured on Cy3–gelatin immobilized on glass-bottomed dishes, fixed and stained for talin2. Scale bar: 20 µm. (D) Quantification of the assembly of talin2 and
talin2S339C in invadopodium-like structures. Data are presented as mean±s.e.m. of three independent experiments. (E) Quantification of invadopodium area.
Data are presented as mean±s.e.m. of three independent experiments. In each experiment, 20 cells from each group were analyzed. t-test, *P<0.05, **P<0.01.
(F–H) Talin2-null MDA-MB-231 cells that expressed EGFP–talin2 (Tln2WT) or –talin2S339C were cultured on Alexa-Fluor-488–gelatin immobilized on
glass-bottomed dishes, fixed and stained for cortactin, using CRISPR-vector-infected cells and talin2-knockout (Tln2 KO) cells as controls. (F) Stable expression
of EGFP–talin2 and EGFP–talin2S339C in talin2-null MDA-MB-231 cells using CRISPR. The numbers after the cells and constructs denote different clones.
(G) Merged TIRF images of matrix degradation and cortactin staining. Scale bar: 20 µm. (H) Expression of EGFP–talin2 in talin2-null MDA-MB-231 cells restored
invadopodial matrix degradation, but that of EGFP–talin2S339C did not. Data are presented as mean±s.e.m. of three independent experiments. t-test, *P<0.05,
**P<0.01, ***P<0.001, compared to talin2 KO cells. (I) A proposed mechanism by which talin2 regulates traction force generation, invadopodium-mediated matrix
degradation and cancer cell invasion.
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talin1 indirectly modulates traction force through promoting cell
spreading, whereas talin2 might directly control traction force by
acting as a mechanical transmitter between integrins and the actin
cytoskeleton.
Although it has been reported that talin2 is not essential for
fibroblast migration (Debrand et al., 2012), we demonstrate that it
plays an important role in cell invasion. Knockout or knockdown
of talin2 inhibited cancer cell invasion (Fig. 6). Furthermore, re-
expression of wild-type talin2 in talin2-null cells rescued cell
invasion, whereas re-expression of talin2S339C, which is deficient in
binding to β-integrin, did not (Fig. 6). The role of talin2 in cell
invasion can be attributed to its effect on invadopodium-mediated
matrix degradation, a key regulatory point for cell invasion (Beaty
and Condeelis, 2014; Bergman et al., 2014; Paz et al., 2014;
Weaver, 2006; Yamaguchi et al., 2006).
Invadopodia are large assemblies that mediate cell invasion
(Beaty and Condeelis, 2014; Paz et al., 2014; Revach and Geiger,
2014). We found that talin2 colocalized with invadopodia to a
considerable extent (Fig. 7). In fact, large and round talin2 staining
spots usually colocalized with invadopodia. Ablation of either
talin1 or talin2 reduced invadopodium-mediated matrix
degradation, but ablation of talin2 had slightly more severe effects
(Fig. 7). Furthermore, expression of full-length wild-type talin2
rescued invadopodium-mediated matrix degradation in talin2-null
cells, whereas expression of talin2S339C, which has reduced binding
to β1-integrin tails, had little effect (Fig. 8). These results suggest
that a strong interaction between talin2 and β-integrin tails is
indispensable for invadopodium-mediated matrix degradation.
Interestingly, regions of high traction forces also coincided with
invadopodia (Fig. 8A). Re-expression of wild-type talin2 but not
talin2S339C in talin2-null cells restored the traction force generation
and invadopodium-mediated matrix degradation (Fig. 5; Fig. 8).
These results suggest that binding of talin2 to β-integrin tails is
essential for the generation of traction force, which in turn drives
invadopodium-mediated matrix degradation and cancer cell
invasion.
It has been reported that podosomes, which are similar structures
to invadopodia, develop in the absence of traction forces (Yu et al.,
2013). We found here that talin2-mediated traction force was
required for invadopodium-mediated matrix degradation. However,
talin2 does not seem to be required for the initial development
of invadopodia because knockout of talin2 did not influence
the assembly of cortactin, an invadopodium marker, into
invadopodium-like structures (Fig. S4). Thus, talin2-mediated
traction force might instead regulate invadopodium stability or
maturation. Although we still do not understand how traction force
regulates invadopodia, our findings fill in the gaps in our existing
knowledge of talin2 and uncover new but fundamental roles of
talin2 in mediating traction force and invadopodium development
during cell invasion.
Talin1 is generally thought to play more important roles than
talin2 in cell migration and embryogenesis – talin1 knockout causes
embryonic lethality in mice (Monkley et al., 2000), whereas talin2 is
not essential for mouse embryonic development (Debrand et al.,
2012). However, as we show here, talin2 generates traction force to
mediate invadopodium formation and cell invasion. The recent
identification of human pathology – the digit deformity fifth finger
camptodactyly – arising from a missense variant, S339L, of the
TLN2 gene (Deng et al., 2016) demonstrates the physiological
importance of residue S339 in talin2 function and the requirement
for strong talin2–integrin linkage for normal development. Both an
S339C and the disease-copying S339L mutant reduced the affinity
of talin2 for integrin and the ability of cells to generate traction
forces. It is possible that the deleterious effect of this mutation on
integrin binding and traction force generation could be the cause of
the developmental abnormality. Interestingly, talin2 has been found
to be downregulated by trastuzumab, a HER2-targeting antibody
drug for treatment of breast cancers (Le et al., 2012). Thus,
inhibition of talin2 function could be a potential strategy for cancer
therapy.
MATERIALS AND METHODS
Reagents
Anti-talin1 (clone 97H6) and anti-talin2 (clone 53.8) antibodies were from
AbD Serotec. Anti-zyxin (clone EPR4302) rabbit monoclonal antibody was
from Abcam. Anti-cortactin mouse monoclonal antibody (clone 4F11) and
anti-Tks5 rabbit polyclonal antibody (clone SH3 #4) were from EMD
Millipore. Anti-cortactin (clone H222) rabbit polyclonal and anti-N-WASP
(clone 30D10) rabbit monoclonal antibodies were from Cell Signaling
Technology. Anti-β1-integrin monoclonal antibody (clone P5D2) was from
R&D Systems. Anti-phosphorylated-FAK (at Y397) [clone 18/FAK
(pY397)] was from BD Biosciences. Anti-talin2 (clone GW22654)
chicken polyclonal and anti-tubulin (clone B-5-1-2) monoclonal
antibodies, bovine skin gelatin and pLKO1 lentivirus shRNAs that
targeted talin1 and talin2 were from Sigma-Aldrich. For western blotting,
anti-tubulin antibody was used at 1:5000 dilution, all other antibodies at
1:1000 dilution. For immunofluorescence staining, anti-zyxin and anti-
phosphorylated-FAK antibodies were used at 1:300 dilution, all other
antibodies were used at 1:100. Talin1 shRNA clones were
TRCN0000123105 (#1) and TRCN0000299020 (#2). Talin2 shRNA
clones were TRCN0000122990 (#1) and TRCN0000122992 (#2).
LentiCRISPRv2 and pSpCas9(BB)-2A-Puro V2.0, which were generated
by Feng Zhang’s laboratory (Ran et al., 2013), were from Addgene. Alexa-
Fluor-488-labeled gelatin and Red FluoSpheres were from Life
Technologies. Cy3 dye was from Click Chemistry Tools. Gelatin was
labeled with Cy3 according to the manufacturer’s instruction. DyLight-488-
conjugated goat anti-mouse IgG (H+L) and Alexa-Fluor-488-labeled goat
anti-chicken IgY (H+L) were from Thermo Scientific. Dylight-550- or -633-
labeled goat anti-mouse and anti-rabbit IgG (H+L) were from
Immunoreagents (Raleigh, NC). Bovine fibronectin and recombinant
human EGF were from Akron Biotech; growth-factor-reduced Matrigel
was from BD Bioscience. Pfu Ultra was from Agilent Technologies. Cold
Fusion Cloning Kit was from System Biosciences (Palo Alto, CA). Anti-
GFP monoclonal antibody and Safectine RU50 transfection kit were
purchased from Syd Labs (Malden, MA). DNA primers were synthesized by
Integrated DNA Technologies.
Plasmid construction
The full-length pEGFP-talin2 plasmid encoding the wild-type protein was
subcloned using the following steps: (1) DNA fragments encoding residues
1–1159 of human talin2 were amplified by using Pfu-Ultra-based PCR and
the human talin2 cDNA clone as the template and 5′-atgcactcgagc-
tatggtggccctgtccttaaagatttgt-3′ and 5′-actgaggtaccgtctcgagcagaatctaacatgg-
cat-3′ as primers, the product was then subcloned into pEGFP-C1 with the
Xho1 and Kpn1 sites; (2) fragments encoding residues 1160–2543 of talin2
were amplified using human cDNA from U2OS cells and 5′-ggctgcatcga-
caaccgacccc-3′ and 5′-tattatctagattagccctcatcttccctcagctc-3′ and subcloned
into the plasmid generated in step 1 into the Not1 and Xba1 sites. pEGFP-
talin21–449 was generated by amplifying DNA fragments encoding residues
1–449 using 5′-ATGCACTCGAGCTATGGTGGCCCTGTCCTTAAAG-
ATTTGT-3′ and 5′-GGGCCCGTCGACTATGAGCCGTGCTCTGCCTT-
CCC-3′ as primers, and subcloning into pEGFP-C1 vector through Xho1
and Sal1 sites. pEGFP-talin11–446 was generated by amplifying DNA
fragments encoding residues 1–446 using 5′-GGGCCCGAATTCTATGG-
TTGCACTTTCACTGAAGATCAG-3′ and 5′-GGGCCCGTCGACTTA-
AGAGCCATGCTCCACTTTCCCC-3′ as primers, and subcloning into
pEGFP-C1 vector into the EcoR1 and Sal1 sites. pEGFP-talin21–449
S339C
was created by performing Pfu-Ultra-based PCR using pEGFP-talin21–449
as template and 5′-GGATCACCAAAGACTGTGTGATGCGCGTGG-3′
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and 5′-CCACGCGCATCACACAGTCTTTGGTGATCC-3′ as primers.
pEGFP-talin11–446
C336S was created by performing PCR using pEGFP-
talin11–446 as template and 5′-CATCACCAAGGAGAGTGTGATGCGAG-
3′ and 5′-CTCGCATCACACTCTCCTTGGTGATG-3′ as primers. pEGFP-
talin11–433 has been described previously (Huang et al., 2009). pQE-
talin11–446 and pQE-talin21–449 were generated by amplifying the DNA
fragments using 5′-GGGCCCGAGCTCATGGTTGCACTTTCACTGAA-
GATCAG-3′ and 5′-GGGCCCGTCGACTTAAGAGCCATGCTCCACT-
TTCCCC-3′, and 5′-ATGCAGAATCCATGGTGGCCCTGTCCTTAAA-
GATTTGT-3′ and 5′-GGGCCCGTCGACTATGAGCCGTGCTCTGCC-
TTCCC-3′ as primers and subcloning into pQE-30 vector into the Sac1
and Sal1 sites, and the BamH1 and Sal1 sites, respectively. The rescue
plasmids pEGFP-talin21–449-R and pEGFP-talin21–449
S339C-R were created
by performing PCR using pEGFP-talin21–449 as template and 5′-GTGAA-
GACCATGCAGTTCGAGCCATCTACAGCTGT-3′ and 5′-ACAGCTG-
TAGATGGCTCGAACTGCATGGTCTTCAC-3′ as primers. The
full-length rescue plasmids pEGFP-talin2-R and pEGFP-talin2S339C-R
were created by digesting full-length pEGFP-talin2 with BsrG1 and
EcoRV, and ligating the resulting larger fragment with the smaller
fragments from the rescue plasmids pEGFP-talin21–449-R and pEGFP-
talin21–449
S339C-R. The full-length pAAVS1-EGFP-talin2WT and pAAVS1-
EGFP-talin2S339C plasmids were created by subcloning talin2 and the
mutant into pAAVS1-EGFP vector, using the same strategy as used
to subclone full-length pEGFP-talin2. The pAAVS1-EGFP vector
was generated by following the following procedures: (1) pEGFP-C1
with BsiWI (at nucleotide 20) and AscI sites (at nucleotide 3533)
was created by sequential PCR using pEGFP-C1 as template and
5′-GTTATTAATAGTAATCACGTACGGGGTCATTAGTTCATAG-3′
and 5′-CT-ATGAACTAATGACCCCGTACGTGATTACTATTAATAAC-
3′ and 5′-CGGAATCGTTTTCCGGCGCGCCGGCTGGATGATC-3′ and
5′-GATCATCCAGCCGGCGCGCCGGAAAACGATTCCG-3′ as
primers; (2) the left and right homologous arms of AAVS1 were
amplified by performing PCR using 5′-TTAATAGTAATCACGTACGT-
GCTTTCTCTGACCAGCATTC-3′ and 5′-ATGAACTAATGACCCCGT-
ACGGCCCCACTGTGGGGTGGA-3′, and 5′-CGGAATCGTTTTCC-
GGCGCGCCACTAGGGACAGGATTGGTG-3′ and 5′-GGATCATCCA-
GCCGGCGCGCCAGAGCAGAGCCAGGAACCC-3′ as primers, respectively,
and the products were subcloned into the modified pEGFP-C1 vector using
the BsiWI and AscI sites, respectively, using the Cold Fusion Cloning Kit.
AAVS1 gRNA was generated by annealing oligos 5′-CACCGCTA-
GTGGCCCCACTGTGGGG-3′ and 5′-AAACCCCCACAGTGGGGC-
CACTAGC-3′, and subcloning into BbsI-digested pSpCas9(BB)-2A-Puro V2.0
vector. LentiCRISPR-TLN1 was created by annealing oligos 5′-CACCG-
GGATCCGCTCACGAATGATG-3′ and 5′-AAACCATCATTCGTGAGC-
GGATCCC-3′, and subcloning into BsmB1-digested lentiCRISPRv2 vector.
LentiCRISPR-TLN2 was generated by annealing oligos 5′-CACCGCGT-
GTCGAGTCATTCGGGAA-3′ and 5′-AAACTTCCCGAATGACTCGA-
CACGC-3′, and subcloning into lentiCRISPRv2 vector. All plasmids were
sequenced by Eurofins MWG Operon (Huntsville, AL).
Cell culture and transfection
CHO-K1 Chinese hamster ovary cells, MDA-MB-231 human breast cancer
cells, U2OS human bone osteosarcoma cells and 293T human embryonic
kidney cells were from the American Type Culture Collection, and were
maintained in Dulbecco’s modified Eagle medium (DMEM; Corning Inc.)
containing 10% fetal bovine serum (FBS), penicillin (100 U/ml) and
streptomycin (100 µg/ml). CHO-K1 and 293T cells were transfected using
Safectine RU50 according to the manufacturer’s protocol. U2OS cells were
transfected using Mirus Ingenio solution using GenePulser Xcell (Bio-Rad
Inc., Hercules, CA).
Knockout of TLN1 and TLN2 with CRISPR
Preparationof viruses and cell infectionwere performed as described previously
(Li et al., 2013;Wu et al., 2011). LentiCRISPR-TLN1 and lentiCRISPR-TLN2
were co-transfected with packaging vectors pMDLg/pRRE, pRSV-Rev and
CMV-VSVG into 293FT cells. Lentiviral particles were collected and used to
infect U2OS cells. The cells were selected with puromycin, and clones were
isolated. TLN1- or TLN2-knockout clones were detected by western blotting
using anti-talin1 and anti-talin2 monoclonal antibodies.
Re-expression of talin2 and talin2S339C in talin2-null cells
The AAVS1 gRNA was co-transfected with pAAVS1-EGFP-talin2WT or
-EGFP-talin2S339C into talin2-null cells. Transfected cells were selected
with neomycin. EGFP-positive cells were sorted by using flow cytometry,
or EGFP-positive clones were isolated by using cloning cylinders.
Protein interaction assays
CHO-K1 cells were transfectedwith pEGFP-talin11–433, -talin11–446, -talin11–
449, or their mutants. At 28 h post transfection, the cells were harvested in lysis
buffer A (50 mM Tris-HCl pH 7.4, 1% NP-40, 150 mMNaCl, 1 mM EDTA
and a protease inhibitor cocktail). Cell lysates were cleared by centrifugation
and incubatedwith glutathione–Sepharose beads loadedwithGSTorGST–β-
integrin tails at 4°C for 2 h. The beads were washed with the lysis buffer four
times and resuspended in SDS sample buffer. Samples were analyzed using
SDS-PAGE and transferred to nitrocellulose membrane for the detection of
interacting proteins. The binding of purified His-tagged proteins to GST–β-
integrin tails was performed in lysis buffer A containing 3 mg/ml BSA
(Fig. 1D) or 0.5 mg/ml gelatin (Fig. 1I).
Cell invasion assays
Cell invasion was performed as described previously (Li et al., 2013).
Briefly, 100 µl of Matrigel (1:30 dilution in serum-free DMEM) was added
to each Transwell polycarbonate filter and incubated at 37°C for 5 h. Cells
were trypsinized and washed three times with DMEM containing 1% FBS.
The cells were resuspended in DMEM containing 1% FBS at a density of
5×105 cells/ml. The cell suspensions (100 µl) were seeded into the upper
chambers, and 600 µl of DMEM containing 1% FBS, 20 ng/ml EGF and
10 µg/ml fibronectin was added to the lower chambers. The cells were
allowed to invade for 12 h (or as indicated) in a CO2 incubator, fixed, stained
and quantified as described previously (Wu et al., 2011).
Traction force measurement
Glass-bottomed dishes were silanized with 0.5% silane, and activated with
0.5% glutaraldehyde. A drop of gel solution containing acrylamide (6%),
bis-acrylamide (0.75%), ammonium persulfate (APS), TEMED and
FluoSpheres® carboxylate-modified beads (diameter 0.2 μm, 1:85 dilution
by volume)was added to the dishes and covered by a coverslip. The coverslip
was removed, and gels were activated with sulfo-SANPAH under UVA light
and then conjugatedwith gelatin (0.2 mg/ml). Cells were plated onto the gels
and traction forcewasmeasured as described previously (Butler et al., 2002),
using an A1 confocal microscope in Lexington VA Medical Center.
Invadopodium assays
Glass-bottomed dishes were coated with 100 μl of warm Alexa-Fluor-488-
conjugated gelatin (0.2 mg/ml) in PBS containing 2% sucrose. The coated
dishes were dried, fixed with pre-chilled glutaraldehyde solution (0.5% in
PBS), washed with PBS and then reduced with 5 mg/ml of sodium
borohydride in PBS. The dishes werewashed extensively with PBS and then
incubated with DMEM containing 10% FBS and antibiotics for 1 h. Cells
were plated at low density onto the dishes and cultured for 24 h, fixed with
paraformaldehyde and stained for talin2 (or talin1) and F-actin. Images were
acquired using a total internal reflection fluorescence (TIRF) microscope.
To measure the area that an invadopodium covered, the images were
converted to 16-bit inverted JPEG format (invadopodia are white spots)
using ImageJ. The images were then opened with NIS Elements,
thresholded (invadopodium spots were precisely covered by red). A
region of interest (ROI) was drawn along the cell edge and the total
invadopodium area was measured using NIS Elements.
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